Targeting mitochondrial dysfunction in neurodegenerative disease: Part II

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2010-04-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14728221003730434PMID 20334487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Intraoperative Near-Infrared Fluorescence Camera System for Optical Image-Guided Cancer Surgery

  2010cited by this paper
• Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons.

  2010cited by this paper
• Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

  2010cited by this paper
• Targeting mitochondrial dysfunction in neurodegenerative disease: Part I

  2010influential reference
• Functional complementation of mitochondrial DNAs: mobilizing mitochondrial genetics against dysfunction.

  2010cited by this paper
• Impaired mitochondrial trafficking in Huntington's disease.

  2010cited by this paper
• LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.

  2010cited by this paper
• Hyperactive Intracellular Calcium Signaling Associated with Localized Mitochondrial Defects in Skeletal Muscle of an Animal Model of Amyotrophic Lateral Sclerosis*

  2009cited by this paper
• Calcium homeostasis, selective vulnerability and Parkinson's disease.

  2009cited by this paper
• Parkin-induced mitophagy in the pathogenesis of Parkinson disease

  2009cited by this paper
• Respiratory Complex I Dysfunction Due to Mitochondrial DNA Mutations Shifts the Voltage Threshold for Opening of the Permeability Transition Pore toward Resting Levels*

  2009cited by this paper
• Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.

  2009cited by this paper
• Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1

  2009influential reference
• What is the mitochondrial permeability transition pore?

  2009cited by this paper
• Clinical experience with high-dose idebenone in Friedreich ataxia

  2009cited by this paper
• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

  2009cited by this paper
• The pathogenesis of Friedreich ataxia and the structure and function of frataxin

  2009cited by this paper
• Indirubin-3'-monoxime inhibits beta-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.

  2009cited by this paper
• Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

  2009cited by this paper
• Nuclear transplantation. Researchers prevent inheritance of faulty mitochondria in monkeys.

  2009cited by this paper
• Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases

  2009cited by this paper
• The changing shape of mitochondrial apoptosis.

  2009cited by this paper
• Implication of the JNK pathway in a rat model of Huntington's disease.

  2009cited by this paper
• Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits.

  2009cited by this paper
• Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

  2009cited by this paper
• PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death

  2009cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• Mitochondrial dynamics in mammalian health and disease.

  2009cited by this paper
• Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model

  2009cited by this paper
• The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity.

  2009cited by this paper
• PINK1 function in health and disease

  2009cited by this paper
• Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.

  2009cited by this paper
• Atg32 is a mitochondrial protein that confers selectivity during mitophagy.

  2009cited by this paper
• Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

  2009cited by this paper
• Cristae formation-linking ultrastructure and function of mitochondria.

  2009cited by this paper
• Effects of overexpression of huntingtin proteins on mitochondrial integrity.

  2009cited by this paper
• Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2

  2009cited by this paper
• Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.

  2009cited by this paper
• Stem cells in amyotrophic lateral sclerosis: state of the art

  2009cited by this paper
• Mitochondrial Hexokinase II Promotes Neuronal Survival and Acts Downstream of Glycogen Synthase Kinase-3*

  2009influential reference
• Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth*

  2009cited by this paper
• Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission*

  2009cited by this paper
• Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response

  2009cited by this paper
• The Parkinson disease‐associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro

  2009cited by this paper
• PPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease

  2009cited by this paper
• Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking.

  2009cited by this paper
• Mitochondrial complementation preventing respiratory dysfunction caused by mutant mtDNA

  2009cited by this paper
• A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

  2009cited by this paper
• NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation

  2009cited by this paper
• Calcium signaling in neurodegeneration

  2009cited by this paper
• Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease

  2009cited by this paper
• Complicated recessive dystonia parkinsonism syndromes

  2009cited by this paper
• Multisystem manifestations of mitochondrial disorders

  2009cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

  2009cited by this paper
• The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1

  2009cited by this paper
• Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases

  2009cited by this paper
• The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease

  2009cited by this paper
• The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI.

  2009cited by this paper
• NADPH oxidase as a therapeutic target in Alzheimer's disease

  2008cited by this paper
• Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

  2008cited by this paper
• Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease

  2008cited by this paper
• Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration

  2008cited by this paper
• Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

  2008cited by this paper
• Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice

  2008cited by this paper
• Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity.

  2008cited by this paper
• De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system.

  2008cited by this paper
• PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons

  2008cited by this paper
• Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6‐hydroxydopamine lesions

  2008cited by this paper
• Reduced Membrane Lipids in the Cortex of Alzheimer’s Disease Transgenic Mice

  2008cited by this paper
• Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

  2008cited by this paper
• Hydrogen Peroxide Promotes Aβ Production through JNK-dependent Activation of γ-Secretase*S⃞

  2008cited by this paper
• Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress

  2008cited by this paper
• CaM kinase Iα–induced phosphorylation of Drp1 regulates mitochondrial morphology

  2008cited by this paper
• Edited GluR2, a gatekeeper for motor neurone survival?

  2008cited by this paper
• Reactive oxygen species generation is modulated by mitochondrial kinases: correlation with mitochondrial antioxidant peroxidases in rat tissues.

  2008cited by this paper
• Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain*

  2008cited by this paper
• Ubiquitin‐dependent and ‐independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases

  2008cited by this paper
• Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

  2008cited by this paper
• Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis.

  2008cited by this paper
• How to live long and prosper: autophagy, mitochondria, and aging.

  2008cited by this paper
• Mitochondrial Approaches for Neuroprotection

  2008cited by this paper
• Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway.

  2008cited by this paper
• Polymorphism in environment responsive genes and association with Parkinson disease

  2008cited by this paper
• Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice

  2008cited by this paper
• The Spinocerebellar Ataxia 12 Gene Product and Protein Phosphatase 2A Regulatory Subunit Bβ2 Antagonizes Neuronal Survival by Promoting Mitochondrial Fission*

  2008cited by this paper
• Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3

  2008cited by this paper
• A New Approach to Treating Alzheimer's Disease

  2008cited by this paper
• Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging.

  2008cited by this paper
• Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

  2008cited by this paper
• A promising new treatment for Alzheimer's disease?

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Mitochondrial Protein Quality Control by the Proteasome Involves Ubiquitination and the Protease Omi*

  2008cited by this paper
• Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction

  2008cited by this paper
• The mTOR pathway and its role in human genetic diseases.

  2008cited by this paper
• Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target?

  2008cited by this paper
• Emerging pathways in genetic Parkinson’s disease: Autosomal‐recessive genes in Parkinson’s disease – a common pathway?

  2008cited by this paper
• Is malfunction of the ubiquitin proteasome system the primary cause of alpha-synucleinopathies and other chronic human neurodegenerative disease?

  2008cited by this paper
• Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

  2008cited by this paper
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007influential reference

• Neuroprotective effect of polyethylene Glycol (PEG-3350) on radiation-induced brain injury via membrane stabilization

  2023cites this paper
• Mic60 is essential to maintain mitochondrial integrity and to prevent encephalomyopathy

  2023cites this paper
• Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease

  2022cites this paper
• Time-Dependent Influence of Sphenocentrum jollyanum Pierre on Neuro-Hepatic Mitochondrial Metabolizing Enzymes in Male Wistar Rats

  2022cites this paper
• Mitochondrial Targeting Probes, Drug Conjugates, and Gene Therapeutics.

  2021cites this paper
• Measurements of mitochondrial NADH pool and NADH production rate in acute brain slices and primary cell cultures using live cell imaging

  2021cites this paper
• Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage

  2021cites this paper
• Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease

  2020cites this paper
• Beneficial Effects of Coconut Oil in Treatment of Parkinson’s Disease

  2020cites this paper
• Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond

  2020cites this paper
• Molecular Mechanisms Underlying the Role of Mitophagy in Neurodegeneration

  2020cites this paper
• Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases

  2020cites this paper
• Visualization of mitochondrial membrane potential in mammalian cells.

  2020cites this paper
• Role of Polyphosphate in Amyloidogenic Processes.

  2019cites this paper
• GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.

  2019cites this paper
• Sterigmatocystin-induced cytotoxicity via oxidative stress induction in human neuroblastoma cells.

  2019cites this paper
• FBS/BSA media concentration determines CCCP’s ability to depolarize mitochondria and activate PINK1-PRKN mitophagy

  2019cites this paper
• Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition

  2018cites this paper
• Activation of the NFAT-Calcium Signaling Pathway in Human Lamina Cribrosa Cells in Glaucoma.

  2018cites this paper
• The Role of Mitochondria in Neurodegeneration Development

  2018cites this paper
• Influence of fisetin combined with hesperidin on chronic mild hyperhomocysteinemia induced cognitive dysfunction and oxidative stress in wistar rats

  2018cites this paper
• Synthetic Cannabinoids in Dementia

  2017cites this paper
• The efficacy and safety of coenzyme Q10 in Parkinson’s disease: a meta-analysis of randomized controlled trials

  2017cites this paper
• Alpha-synuclein and beta-amyloid - different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration.

  2017cites this paper
• Deficiency of Parkinson’s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation

  2017cites this paper
• Interaction of misfolded proteins and mitochondria in neurodegenerative disorders.

  2017cites this paper
• Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation

  2017cites this paper
• Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia

  2017cites this paper
• Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers

  2017cites this paper
• Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells

  2017cites this paper
• Mitochondria in the pathophysiology of Alzheimer's and Parkinson's diseases.

  2017cites this paper
• Photo-Induced Oxidative Stress Impairs Mitochondrial Metabolism in Neurons and Astrocytes

  2017cites this paper
• Mitochondrial calcium imbalance in Parkinson's disease.

  2017cites this paper
• Chapter 5 – Mitophagy

  2017cites this paper
• Redox biology and the interface between bioenergetics, autophagy and circadian control of metabolism.

  2016cites this paper
• Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function

  2016cites this paper
• Mitochondrial dysfunction associated with glucocerebrosidase deficiency

  2016cites this paper
• Comparative Analysis of Intrahippocampal Amyloid Beta (1-42)and Intracerbroventricular Streptozotocin Models of Alzheimer'sDisease: Possible Behavioral, Biochemical, Mitochondrial, Cellu lar andHistopathological Evidences

  2016influential citation
• Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation

  2016cites this paper
• Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function

  2016cites this paper
• Measurement of mitochondrial NADH and FAD autofluorescence in live cells.

  2015cites this paper
• The emerging theme of redox bioenergetics in health and disease

  2015cites this paper
• The role of mitochondrial dysfunction in age-related diseases.

  2015cites this paper
• Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration

  2015influential citation
• Mitochondrial Dysfunction in Parkinson's Disease

  2015cites this paper
• Mitochondrial Ca(2+) in neurodegenerative disorders.

  2015cites this paper
• In situ investigation of mammalian inorganic polyphosphate localization using novel selective fluorescent probes JC-D7 and JC-D8.

  2014cites this paper
• Mitochondrial Membrane Fluidity is Consistently Increased in Different Models of Huntington Disease: Restorative Effects of Olesoxime

  2014cites this paper
• Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer׳s disease.

  2014cites this paper
• Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.

  2014cites this paper
• A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

  2014cites this paper
• Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

  2014cites this paper
• Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam.

  2013cites this paper
• Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration

  2013cites this paper
• Role of NAD+, Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders

  2013cites this paper
• Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes.

  2013cites this paper
• Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease

  2012cites this paper
• Impaired mitochondrial function in psychiatric disorders

  2012cites this paper
• Potential Therapies for Mitochondrial Dysfunction

  2012cites this paper
• An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies

  2012cites this paper
• Oxidative Stress in Neurodegenerative Diseases and Ageing

  2012cites this paper
• Voltage-gated calcium channels and Parkinson's disease.

  2012cites this paper
• Opposite caudal versus rostral brain nitric oxide synthase response to generalized seizures in a novel rodent model of reflex epilepsy.

  2012cites this paper
• Mitochondria, calcium-dependent neuronal death and neurodegenerative disease

  2012cites this paper
• Mechanism of Oxidative Stress in Neurodegeneration

  2012cites this paper
• Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism

  2011cites this paper
• High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria

  2011cites this paper
• Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function

  2011cites this paper
• Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases.

  2011cites this paper
• Effect of β‐amyloid (25–35) on mitochondrial function and expression of mitochondrial permeability transition pore proteins in rat hippocampal neurons

  2011cites this paper
• Mitophagy and Parkinson's disease: The PINK1–parkin link

  2011cites this paper
• From axonal transport to mitochondrial trafficking: What can we learn from Manganese-Enhanced MRI studies in mouse models of Alzheimers disease?

  2011cites this paper
• The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach

  2010cites this paper
• Modeling mitochondrial encephalomyopathy in Drosophila.

  2010cites this paper
• Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea

  2010cites this paper